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Ancient protein analysis provides clues to human life and
diseases from ancient times. Here, we performed shotgun
proteomics of human archeological bones for the first time,
using rib bones from the Hitotsubashi site (AD 1657–1683)
in Tokyo, called Edo in ancient times. The output data
obtained were analysed using Gene Ontology and label-free
quantification. We detected leucocyte-derived proteins,
possibly originating from the bone marrow of the rib.
Particularly prevalent and relatively high expression of
eosinophil peroxidase suggests the influence of infectious
diseases. This scenario is plausible, considering the
overcrowding and unhygienic living conditions of the Edo city
described in the historical literature. We also observed age-
dependent differences in proteome profiles, particularly for
proteins involved in developmental processes. Among them,
alpha-2-HS-glycoprotein demonstrated a strong negative
correlation with age. These results suggest that analysis of
ancient proteins could provide a useful indicator of stress,
disease, starvation, obesity and other kinds of physiological
and pathological information.
2017 The Authors. Published by the Royal Society under the terms of the Creative Commons
Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted
use, provided the original author and source are credited.
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1. Introduction
Ancient proteins have been studied with the aim of revealing the life and diseases of past humans, species
identification and evolution [1–3]. Immunological methods were applied to archaeological human bones
as early as the 1980s [4]. Haemoglobin, serum albumin (ALB) and immunoglobulin G (IgG) were studied
using immunological methods for species identification and for detecting immune responses [5–7].
In recent years, proteomics analysis by liquid chromatography tandem mass spectrometry
(LC-MS/MS) has attracted more attention owing to its accuracy and robustness and to the remarkable
improvement in instruments and protein databases; this method has also been applied to ancient
remains [8–11]. The first LC-MS applied to archaeological remains was conducted by Schweitzer et
al. [12]. Then shotgun proteomics analysis was performed on a 43 000-year-old woolly mammoth
bone [8]. Since then, the method has been applied to other species [9–11,13–16]. With regard to
archaeological human bones, ancient protein analyses have been performed to detect disease and
immune response [17,18]; however, to date, shotgun proteomics analysis has not been used to profile
the bone proteome of archaeological human remains. In this study, we present the results of shotgun
proteomic profiling of archaeological human bones. We performed shotgun proteomics of human
remains using eight rib bones excavated from the Hitotsubashi site of the Edo period, expecting to
acquire physiological information.
We used rib samples from eight skeletons excavated from the Hitotsubashi site (AD 1657–1683) in
Tokyo, Japan. The Hitotsubashi site is located in the city of Edo, the former name for Tokyo, and is known
for its rapid urbanization and stressful living environment [19–21]. Our findings suggest that the bone
proteome represents a source of information about immune system activity and age-related changes.
Our work demonstrates that the proteomes of archaeological bone represent a source of biomolecular
information for the reconstruction of physiological and pathological processes that occurred in antiquity
but cannot be detected using other bioarchaeological methods.
2. Material and methods
2.1. Human bone samples
Two infants and six adults, including four elderly adults (more than 60 years old), were obtained from
the skeletal collection of the Hitotsubashi site (AD 1657–1683) in Tokyo, Japan. The chronological age
was determined on the grounds of the stratigraphic layer, which is between the Great fire of Meireki
(AD 1657) and the fire of Tenna (AD 1684). The individuals buried in this graveyard are townspeople,
known from the fact that the largest proportion of graves consisted of the wooden coffins typically
used for the lower social classes. Nagaoka & Hirata [21] had reported the sex and age at death of the
adult skeletons used in this study. Sex was determined by the sexual dimorphism of the pelvis using the
dimorphic criteria of the pelvis including the greater sciatic notch [22–24], preauricular sulcus [23–25],
ventral arc [26], subpubic concavity [26] and medial aspect of the ischiopubic ramus [26]. Age at death for
each individual was estimated by the observation of the auricular surface of the ilium using the method
of Buckberry & Chamberlain [27]. The auricular surface of the ilium is resistent to decay in forensic and
archaeological contexts, and it seems to cover a wide range of ages up to elderly individuals [28]. The age
estimation at death of adults aged more than 15 years was based on the chronological metamorphosis of
the auricular surface of the ilium. Buckberry & Chamberlain [27] developed a quantitative system of 5–19
composite scores according to five morphological traits of the auricular surface: transverse organization,
surface texture, microporosity, macroporosity and apical change. The 5–19 composite scores of the five
traits are then classified into seven stages. Each obtained stage of the auricular surface of the ilium is
then transformed into an average age at death with standard deviation shown in the data of Buckberry
& Chamberlain [27]. Although the age at death estimation is more difficult in adults than in sub-adults,
Murlhern & Jones [29] tested the reliability of the revised method using 309 individuals from the Terry
Collection and detected that the Buckberry and Chamberlain’s method [27] improved the accuracy of age
estimation for elderly adults. The age at death of sub-adults was estimated by the degree of formation
and eruption of teeth [30,31].
2.2. Protein sample preparation
In order to prevent contamination, surfaces were removed from bone samples with sandpaper. Samples
(30–50 mg) were wrapped in clean aluminium foil and fragmented into powder using a conventional
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hammer. The hammer was cleaned with bleach and ethanol, repeatedly. Powdered bone samples
were washed three times with 300µl 0.5 M EDTA (pH 8.0), followed by incubation at 4 ◦C for 24–
48 h with agitation. Samples were washed again three times with 100µl 0.1 M Tris (pH 8.0). Samples
were suspended in 300µl 6 M guanidinium hydrochloride (GuHCl), 10 mM Tris (2-carboxyethyl)
phosphine, 20 mM chloroacetamide and 200 mM Tris (pH 8.0). Soft organic pellets eventually released
after demineralization were disrupted using single-use individually sealed disposable micropestles
(Eppendorf), cleaned before use with a 5% bleach solution and 95% ethanol (v/v). Without separating
supernatants and the residual bone powder, samples were heated at 80 ◦C for 2 h, and cooled to room
temperature. LysC-Trypsin mix, 1/100 by amount of protein, was added to the samples for protein
digestion. Mixed samples were incubated at 25 ◦C for 30 min then diluted to 2 M GuHCl with 25 mM
Tris (pH 8.0), followed by incubation at 37 ◦C overnight with agitation. Digestion was terminated with
10% trifluoroacetic acid to a final concentration of 1%. After centrifugation at 14 000 g for 10 min, the
tryptic peptides in the supernatant were immobilized on C18 stage tips as previously described [8].
Peptide mixtures were analysed by online nanoflow reversed-phase C18 LC-MS/MS, as described
previously [32]. Briefly, peptides were separated on a 50 cm PicoFrit column (75 mm inner diameter)
in-house packed with 1.9 mm C18 beads (Reprosil-AQ Pur, Dr. Maisch) on an EASY-nLC 1000 system
connected to a Q-Exactive HF (Thermo Scientific) on a 165 min gradient. The Q-Exactive HF was operated
in data-dependent top 10 mode. Full scan mass spectra were recorded at a resolution of 120 000 at m/z
200 over the m/z range 300–1750 with a target value of 3×106 and a maximum injection time of 20 ms.
HCD-generated product ions were recorded with a maximum ion injection time set to 108 ms through a
target value set to 2×105 and recorded at a resolution of 60 000 with a fixed first mass set to m/z 100.
2.3. Data analysis
MS/MS spectra in ‘.raw’ file format were processed with MAXQUANT v. 1.5.3.28 [33] and
ANDROMEDA [34] against the human reference proteome (UniProtKB, downloaded on 13 December
2015). In every search, spectra matched against the common contaminants database were removed except
ALB, a common protein in bones [35].
Although bovine serum albumin (BSA) can be a common contaminant in proteomics laboratories,
it has been previously demonstrated that endogenous ALB from extinct species can be confidently
retrieved from ancient bones [8,16,35]. We validated the authenticity of the human serum albumin
retrieved in this study by checking for the absence of BSA peptides in all the samples. All but one
peptide of ALB had the same sequence as human, not bovine (the one peptide sequence was the same as
both human and bovine). This indicates that the contamination of BSA had little impact, if any. We also
checked the evidence of deamidation in ALB peptide, so we included ALB in data analysis.
Cysteine carbamidomethylation was used as a fixed modification. Oxidation (M and P), Gln →
pyro-Glu (N-term Q), Glu → pyro-Glu (N-term E) and deamidation (N and Q) were used as variable
modifications. The peptide tolerance, in the main search, was set to 5 ppm, while the tolerance for
MS/MS match was set to 20 ppm. Up to seven modifications per peptide and up to two missed cleavages
were allowed. The false-discovery rate was set at 1%. Other parameters were used as those pre-set
in the software. The first protein of major protein IDs was used as a protein name. The deamidation
rate of collagen (COL1A1 and COL1A2) was calculated as the total number of deamidated glutamine
residues divided by the total number of glutamine residues. The mass difference between the deamidated
monoisotopic peak and the 13C peak of the amidated form of the same peptide is 19.34 mDa. Previous
studies demonstrated that the use of an orbitrap mass spectrometer with high mass measurement
accuracy and high resolving power, like the one used in this study (Q-Exactive HF), and a peptide
tolerance value like the one we imposed, 5 ppm, enable correct assignment of deamidated peptides [36].
In order to compare the amount of proteins among samples, detected proteins were quantified using
the exponentially modified protein abundance index (emPAI) score [37]. The emPAI score is calculated
using the number of detected peptides normalized by the number of theoretically observable ones.
The emPAI score of basic salivary proline-rich protein 3 (PRB3) was quite high because the number of
theoretically observable peptides is two, which is too small for calculating emPAI. We therefore excluded
this protein. The emPAI scores of the remaining proteins were normalized, respectively, by the score of
collagen (COL1A1). In order to detect proteins that correlated with age, Pearson’s correlation analysis
between age and normalized emPAI score was performed on the proteins that included more than 10
unique peptides in total samples. As multiple comparisons were performed, Bonferroni’s correction was
used for correlation analysis. We used the corr.test and p.adjust functions in R for statistical analysis.
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Table 1. Summary of the proteins extracted from samples. Proteins: number of identified unique proteins from each sample. Peptides:
thenumber of identifieduniquepeptides fromeach sample. Deamidation (%): thedeamidation rate of glutamine calculatedusingCOL1A1
and COL1A2.
sample ID sex age (years) proteins peptides deamidation (%)
H-9 — 0.75 173 794 10.1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H-142 — 4 162 497 13.3
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H-91 male 29 ± 6.7 158 341 4.1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H-206 male 38 ± 13.1 188 782 9.2
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H-24 female 60 ± 13.0 127 387 10.0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H-88 male 60 ± 13.0 175 483 10.0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H-160 male 60 ± 13.0 160 520 10.9
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H-162 female 72 ± 12.7 145 554 10.9
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
To reveal protein function, we used the Gene Ontology (GO) term. The PANTHER statistical over-
representation test [38] was conducted to identify functional GO annotations that were enriched in each
individual. We used the ‘GO experimental only’ database for reliable annotation. Focusing on the fold
change of proteins associated with developmental function, we calculated the correlation test between
age and fold change of proteins that have the ‘developmental process’ term (GO: 0032502). We also used
the STRING database [39] to create a network of functional relationships between the identified top
30 proteins.
3. Results
3.1. Proteins detected from archaeological human bones
We applied shotgun proteomics using LC-MS/MS to the skeletal samples excavated from the
Hitotsubashi site in Tokyo (AD 1657–1683, Edo period, Japan). The number of detected proteins varied
among individuals from 127 to 188 (table 1). There were no significant correlations between the estimated
age at death and the number of detected proteins/unique peptides (Pearson’s r= −0.4082, p = 0.3154 for
proteins; r= −0.3480, p = 0.3983 for unique peptides). Venn diagrams indicated that infants and adults
shared 33 proteins, while adults and elderly adults shared 46 proteins (figure 1a). Infants and elderly
adults shared 21 proteins. The common proteins between females and males were less than those among
males (figure 1b). Elderly females shared 25 proteins with adult males and 23 proteins with elderly males.
Adult males and elderly males shared 48 proteins. The composition of proteins was shown in figure 2.
This indicates that approximately half of total proteins were collagens and extracellular matrix. Plasma
proteins accounted for 10–25% of total proteins. Proteins expressed in granules, the intracellular region
and membrane were also detected from each bone sample.
With regard to the presence of unique peptides, COL1A1 had the largest number of unique peptides in
all individuals, followed by COL1A2. Other collagens, such as COL2A1, COL5A1, COL5A2, COL12A1
and COL22A1, were also detected in almost all samples. Plasma proteins, such as ALB, prothrombin
(F2) and coagulation factor IX (F9) were also detected. The top 30 proteins, with the exception of the
olfactomedin-like protein (OLFML3), were functionally connected to at least one other protein in the
STRING network (electronic supplementary material, figure S1). Osteocalcin (BGLAP), one of the major
components of bone, was detected in all samples. Two proteins related to osteoclast regulation were
detected in some of the samples: macrophage colony-stimulating factor 1 (CSF1), which plays an essential
role in the proliferation and differentiation of osteoclasts [40], and tumour necrosis factor receptor
superfamily member 11A (TNFRSF11A), which is essential for RANKL-mediated osteoclastogenesis [41].
3.2. Leucocyte-derived proteins in archaeological human bones
We identified proteins derived from leucocytes, such as neutrophils and eosinophils, in archaeological
human bones. Warinner et al. [42] found leucocyte-derived proteins in human dental calculus; however,
to date, no research detecting these proteins in archaeological human bones, including immunological
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Figure 1. Venn diagrams of proteins between (a) life stages and (b) sex. (a) Infant: H-9 and H-142; adult: H-91 and H-206; elderly adult:
H-88 and H-160. (b) Adult male: H-91 and H-206; elderly female: H-24 and H-162; elderly male: H-88 and H-160.
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Figure 2. The composition of detected proteins. X-axis corresponds to sample ID of each individual.
analysis, has been performed. To our knowledge, this is the first study detecting leucocyte-derived
proteins in archaeological human bones.
Neutrophils are the most abundant white blood cells and are the first-responders among
inflammatory cells to migrate towards the site of inflammation during its beginning phase, particularly
as a result of bacterial infection [43]. A variety of neutrophil-derived proteins were detected
from the Hitotsubashi samples, including neutrophil defensin 1/3 (DEFA1/3), neutrophil elastase
(ELANE), myeloperoxidase (MPO), azurocidin (AZU1) and cathepsin G (CTSG). DEFA1/3, ELANE
and MPO are characteristic proteins in azurophilic granules, which are a type of granule found in
neutrophils [43,44]. The unique peptides in these proteins were significantly correlated to each other
(electronic supplementary material, table S1).
Eosinophils have a key role in allergic and inflammatory processes, including asthma and host
resistance to parasites, such as helminths, but they also exhibit antimicrobial activities towards bacterial,
viral and protozoan pathogens, and mediate hypersensitivity diseases [45]. In this study, eosinophil
peroxidase (EPX) was detected in all samples; EPX is uniquely expressed in eosinophils and not in other
cells [45]. Another protein expressed in eosinophil granules, proteoglycan 2 (PRG2), was also detected,
and the number of unique peptides was significantly correlated with that of EPX (Pearson’s r= 0.7782,
p< 0.05). These results indicate the presence of eosinophils in archaeological human bones. Eosinophil-
derived neurotoxin (EDN/RNASE2) and eosinophil cationic protein (ECP/RNASE3) were not detected,
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Figure 3. Age-related changes of proteins. (a) Relationship between age and fold change of the number of proteins annotated with the
GO term ‘developmental process’ (GO: 0032502) (Pearson’s r = −0.7386,p = 0.03638). (b) Relationshipbetweenageand thenormalized
emPAI value of AHSG (Pearson’s r = −0.9826, p = 1.295 × 10−5).
likely because of the small amount of the proteins or the difficulty of detecting proteins with relatively
short sequences [46].
3.3. Gene Ontology enrichment analysis
We performed GO enrichment analysis in order to estimate what kinds of processes were over-
represented. Bone formation processes, such as ‘collagen fibril organization’ and ‘ossification’, were
enriched (electronic supplementary material, figure S2). There were also processes associated with
non-collagenous proteins (e.g. ‘extracellular structure organization’, ‘extracellular matrix organization’
and ‘cell adhesion’). The processes most enriched in infants were associated with developmental
processes, including ‘tissue development’, ‘multicellular organismal development’, ‘single-organism
developmental process’, ‘developmental process’ and ‘anatomical structure development’, Age at death
was significantly negatively correlated with the fold change of the ‘developmental process’ (Pearson’s
r= −0.7386, p< 0.05; figure 3a). The numbers of proteins involved in the ‘ossification’ process in infant
and adult samples were twice as large as that in the elderly adult (electronic supplementary material,
figure S2). In GO Cellular Component terms, the ‘extracellular matrix’ was enriched most remarkably
in the infant (electronic supplementary material, figure S3). In GO Molecular Function terms, ‘growth
factor binding’ was clearly enriched in the infant (electronic supplementary material, figure S4).
3.4. Protein quantitation using exponentially modified protein abundance index
In order to compare the amount of proteins in each sample, we used the emPAI score, one of the most
common label-free approaches used for absolute quantification of shotgun proteomics [37]. EmPAI scores
of all proteins were normalized by that of COL1A1. The sum of the normalized emPAI scores for non-
collagenous proteins showed significantly negative correlation with age (Pearson’s r= −0.7088, p< 0.05).
There were proteins with normalized emPAI scores showing a significantly negative correlation with
age (table 2). In particular, the normalized emPAI score of alpha-2-HS-glycoprotein (AHSG) showed a
strong, significantly negative correlation with age (Pearson’s r= −0.9826, p = 1.295 × 10−5; figure 3b).
The normalized emPAI scores of ALB, insulin-like growth factor-binding protein 5 (IGFBP5), kininogen-
1 (KNG1) and pigment epithelium-derived factor (SERPINF1) also showed a significantly negative
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Table 2. Correlation between normalized emPAI scores and age. p-Value after Bonferroni’s correction is marked with an asterisk.
gene name p-value p-value* Pearson’s r
SERPINF1 0.01933536 0.8894264 −0.7912284
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ALB 0.0168598 0.775551 −0.8010759
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AHSG 1.29×10−5 5.95×10−4 −0.9826241
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
KNG1 0.007853061 0.3612408 −0.8477033
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IGFBP5 0.001842309 0.08474621 −0.9075273
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
correlation with age (electronic supplementary material, figure S5). Among these proteins, AHSG was the
only protein whose emPAI score was still statistically significant after multiple test correction (table 2).
There were no emPAI scores that significantly and positively correlated with age. AHSG, also known as
fetuin-A, is produced not only in the liver but also in osteocytes [47], and is characterized by particularly
high mineral affinity. IGFBP5 is an IGF-binding protein involved in the regulation of cell growth and is
the most abundant IGFBP stored in bone, where it controls osteoblast differentiation and osteoblast–
osteoclast crosstalk [48]. Kininogens are inhibitors of thiol proteases with primarily two isoforms,
high-molecular-weight kininogen (HMWK) and low-molecular-weight kininogen (LMWK). HMWK is
essential for blood coagulation and the assembly of the kallikrein–kinin system, while LMWK is not
involved in blood coagulation. SERPINF1 is a multifunctional secreted protein with anti-angiogenic, anti-
tumorigenic and neurotrophic functions. A form of osteogenesis imperfecta, a heritable bone dysplasia
characterized by bone fragility and deformity and growth deficiency with a mineralization defect, is
caused by mutations in SERPINF1 [49].
There are proteins highly expressed only in infants. Periostin (POSTN), formerly named
osteoblast-specific factor-2, was originally cloned from a mouse osteoblast cell line [50]. Its function is as
a cell-adhesion molecule for preosteoblasts and it is thought to be involved in osteoblast recruitment [50,
51]. POSTN was remarkably high in the youngest infant (unique peptides = 11, normalized emPAI =
0.0685), although no peptide was found in adult and elderly adult samples. Apolipoprotein A-1 (APOA1)
is the major protein component of high density lipoprotein (HDL) in plasma. The expression level of
APOA1 in blood has been reported to decrease with age [52,53]. In this study, APOA1 was detected only
in the youngest infant (0.75 years old), which is consistent with the previous research [52,53].
4. Discussion
4.1. The authenticity of the proteomic data
In general, the problems of ancient biomolecule analysis are contamination from the modern
environment and the preservation of endogenous molecules. Discerning contaminant molecules from
endogenous molecules is especially problematic, particularly for ancient DNA analysis. However,
in the case of ancient protein analysis, there is no amplification process (e.g. PCR for DNA); thus,
contaminant proteins have less of an effect on the endogenous proteins. In addition, the expression
patterns of proteins are tissue-specific (e.g. keratin from human epidermis), making the identification
of contaminant proteins easier. The proteomic analysis software MAXQUANT also provides a list of
common protein contaminants [33]; thus, we removed proteins included in the list, with the exception of
albumin, which is a common protein detected from archaeological bones [8,35]. To address the issue of
endogenous molecule quality, proteomic data from the samples were assessed using two indices: the rate
of deamidation and the proportion of type I collagen. Deamidation is an indicator of the preservational
quality, and the rate of deamidation of glutamine range is 0–20% in bones of 0–2000 years ago [54]. In
this study, the rate of deamidation was 10% on average (range 4–13%; table 1), which is compatible with
bones dating ca 500 years before present. Type I collagen accounts for 90% of the organic matter of bone,
and the collagen triple helix is composed of two alpha 1 chains and one alpha 2 chain. Therefore, it
is expected that the proportion of type I collagen is dominant in archaeological bones. In our samples,
collagen type I alpha 1 (COL1A1) had the largest number of unique peptides followed by collagen type I
alpha 2 (COL1A2). The number of unique COL1A1 peptides showed significant correlation with that
of COL1A2 (Pearson’s r= 0.9715, p = 5.636 × 10−5). These findings indicate that the proteomics data
accurately reflect the composition of the modern bone proteome. In addition, the atomic C/N ratios
and gelatin yields, the proxies for the preservation of collagen used in isotope analysis, indicated that
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Figure 4. Relative ratios of proteins expressed in neutrophils (MPO and ELANE) and eosinophils (EPX and PRG2). Expression levels of
DEFA1/3 were used as a standard. Open circles are from the Hitotsubashi samples. Closed circles are from reference data of The Human
Protein Atlas [61].
the samples from the Hitotsubashi site were well preserved [55]. From these results, we confirmed the
preservation of the proteins in our samples.
4.2. The presence of leucocyte-derived proteins
An interesting finding in this study was the presence of proteins derived from leucocytes, such as
neutrophils and eosinophils. These proteins have not been found in previous studies of archaeological
bone [3,8,9,16]. Leucocytes play a critical role in the immune system, so this finding shows the potential
of ancient protein analysis for reconstructing the disease, health status and stress profiles of past humans.
These proteins were possibly derived from red bone marrow in the rib samples. Red marrow is
haematopoietically active and contains erythrocytes and leucocytes, whereas yellow marrow is made
almost entirely of fat, with few haematopoietic elements [56]. All bone marrow is haematopoietic red
marrow during infancy. With age, red marrow is gradually converted to the fatty yellow type. By early
adulthood, the yellow type makes up two-thirds of the total bone marrow, while red bone marrow
remains specifically in the ribs, vertebrae and os coxae [57,58]. In this study we used rib samples, which
may explain why we could detect ample leucocyte-derived proteins. For instance, these proteins are
scarcely detected in the femur [59].
Although eosinophils constitute only approximately 1–4% of leucocytes of human bone marrow [60],
we detected adequate numbers of unique peptides of EPX in all samples. In addition, some individuals
showed higher ratios of eosinophil-derived proteins (EPX and PRG2) compared with bone marrow
reference data (figure 4). We also found that the number of unique peptides was significantly correlated
with that of EPX (Pearson’s r= 0.7782, p< 0.05). This may be due to the increase of eosinophils in rib
samples. The number of eosinophils increases in association with pathogenesis during asthma, allergic
and, particularly, parasitic disease. In the city of Edo, high population pressure led to overcrowding
and unhygienic living conditions. It has been reported that there were repeated epidemics among
the citizens of Edo at that time [62]. Regarding the Hitotsubashi site, Hirata [20] found that severe
cribra orbitalia resulting from iron deficiency anemia was prevalent in the population. In addition,
Nagaoka & Hirata [21] reported a relatively short lifespan tendency for the people of Hitotsubashi.
Yamamoto [19] reported that a high incidence of dental enamel hypoplasia was found in Hitotsubashi
samples. These authors concluded that people residing at the Hitotsubashi site lived under a highly
stressful environment [19–21]. According to the historical literature, helminth infection was prevalent
during the Edo period [63–65]. These reports support our observation that eosinophil-derived proteins
were highly expressed in individuals excavated from the Hitotsubashi site and this may reflect the
presence of infectious disease, such as parasite infections.
4.3. Age-related changes in the proteins of human bones
The protein profile, structure and composition of bone change with age [66]. Indeed, levels of certain
proteins in bone are related to age. For example, the content of non-collagenous proteins, such as AHSG
and ALB, decreases with age in bone [67,68]. A recent study sought to determine protein groups whose
levels change with development in zebrafish bone [69]. However, whether archaeological bones also
show these age-related changes is unknown.
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Our analysis indicates, for the first time, that proteomics data from archaeological bones reflect the
life stages of individuals. This is supported by three levels of analysis: whole profiling by Venn diagram,
the functional protein groups by GO enrichment analysis, and individual protein levels by quantification
analysis.
First, the Venn diagram analysis among life stages (infant, adult and elderly adult) showed that
the number of shared proteins between infant and elderly adult was the smallest among the three
comparisons (figure 1a). The number of proteins shared by infant and adult was more than that shared by
infant and elderly adult, and proteins were shared most between adult and elderly adult. This indicates
that the component of proteomics differs most between infants and elderly adults (figure 1a).
Second, GO analysis suggests that the proteomic profile reflects the life stage of individuals. GO
Biological Process terms associated with development were most abundant in infant bones (electronic
supplementary material, figure S2). Specifically, the age of the individuals was significantly negatively
correlated with the fold change of the ‘developmental process’ (figure 3a). For the ‘ossification’ GO term,
the number of proteins involved in that process in infants and adults was twice as large as that of the
elderly adult. In GO Cellular Component terms, the ‘extracellular matrix’ was enriched most remarkably
in the infant (electronic supplementary material, figure S3). In GO Molecular Function terms, ‘growth
factor binding’ was clearly enriched in the infant (electronic supplementary material, figure S4). These
results suggest that infants have more proteins involved in development and growth.
Third, quantitative analysis using emPAI suggests that there are some proteins whose expression
undergoes age-related changes. Sum emPAI scores for non-collagenous proteins in total showed
significantly negative correlation with age (Pearson’s r= −0.7088, p< 0.05). In regard to each protein,
the emPAI score of AHSG correlated most strongly with age (figure 3b). The normalized emPAI scores
for ALB, IGFBP5, KNG1 and SERPINF1 also negatively correlated with age (electronic supplementary
material, figure S5).
It is noteworthy that AHSG, ALB and IGFBP5 reportedly show age-related changes in modern bone.
Wilson et al. [70] reported that the levels of AHSG and ALB in fetal bone were at least one order of
magnitude greater than those of adult cortical bone. Quelch et al. [67] reported that AHSG, ALB and
sialic acid were present in higher concentrations in neonatal bone compared with bones from children
and adults. The concentration of AHSG in neonatal bone was approximately three times higher than
that in bone from children, and seven times higher than that in adult bone. The ALB concentration in
neonatal bone was one-and-a-half times higher than that in child bone and twice as higher than that in
adult bone. With regard to IGFBP5, Mohan et al. [71] reported that a decrease in IGFBP5 has been linked
to age-related bone loss. Our results from archaeological human bones indicated that the levels of AHSG
were correlated most strongly with age; ALB and IGFBP5 also showed a tendency to decrease with age.
These results are consistent with the previous research in modern human bone [67,70,71].
Owing to high concentrations of AHSG in fetal serum, multiple functions related to development
have been suggested [72,73]. Following collagen, AHSG is one of the most abundant proteins in
bone and its ability to bind calcium and other minerals supports the notion that it is essential for
osteogenesis [74,75]. Current studies suggest that circulating AHSG is highest during infancy, declines
in childhood and varies in adults owing to genetic factors, obesity and diet [73]. AHSG might also be
impacted by the natural ageing process [76]. It has been demonstrated that the level of AHSG in bone
is also highest in infants and declines with age [67,68,70]. From these findings, we believe our results,
indicating high levels of AHSG in infants that decline with age, are consistent and generalizable to other
archaeological bones.
4.4. Insights of proteomics analysis in archaeological human bones and future perspective
Shotgun proteomics enabled us to analyse more than 100 proteins with accuracy and robustness. Our
findings confirmed by multiple proteins that leucocytes such as neutrophils and eosinophils remained
in archaeological rib bones. We also found certain proteins to be significantly correlated with age. In
addition, we used samples of rib bone for which morphological information related to disease and age
did not previously exist. Collectively, our study has demonstrated significant achievement in ancient
proteomics, revealing biological processes not visible on the exterior.
Leucocyte-derived proteins provide new insights of paleopathological interest. IgG has been studied
by enzyme-linked immunosorbent assay (ELISA) [77], Western blot [78] and LC-MS/MS [18] for
detecting the immune responses of the past; however, some studies found it difficult to detect IgG
in archaeological bone [6,18]. By contrast, leucocyte-derived proteins such as DEFA1/3 and EPX were
prevalently detected in archaeological rib bones in this study. This suggests that these proteins may be
better target molecules for studying the immune system.
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Furthermore, our results suggest that rib bone is suitable for detecting proteins abundant in bone
marrow, particularly for leucocyte proteins. Vertebrae and os coxae are also promising bone elements
owing to the remaining red bone marrow [57]. Currently, no method exists to detect an infection in
an individual from their bones, except severe stages of some diseases morphologically apparent, such as
syphilis and tuberculosis. The particularly prevalent helminths are difficult to detect, because they do not
seriously damage the human body. In this study, eosinophils, involved in allergic reactions or parasitic
infections, were prevalently detected, which could be related to infectious disease during the Edo period.
However, while highly suggestive, our results are insufficient to verify the existence of an infection, thus
more rigorous quantitative methods, such as selected reaction monitoring (SRM), would be favourable
as a next step.
Our results indicate that AHSG emPAI scores correlate strongly with age. Previous studies have
suggested that AHSG exists prevalently in archaeological bone [35], which might suggest that we can
estimate life stages of other species or chronologically older samples. There were other proteins that
correlated with age or that were expressed only in infants, such as ALB, IGFBP5, POSTN and APOA1.
Even though the sample size was small, the data were consistent with previous findings of modern
samples. Based on the relative amount of these proteins, we can confirm and further narrow down
the estimated age range for each individual, especially when dealing with remains from sub-adults.
The full potential of the innovative approach we present here should, however, be fully validated with
future research.
The analysis of ancient proteins could provide a useful indicator of stress, disease, starvation, obesity
and other kinds of physiological and pathological information. For example, ancient proteins have
revealed past diseases such as osteogenic sarcoma and prostate carcinoma [17,79]. Scott et al. [80] reported
that osteocalcin analysis is promising for detecting stress. The analysis of multiple proteins is preferable
to confirm these results.
The field of ancient DNA has entered a new era of genomics and has provided valuable genetic
information about past human history [81]; nevertheless, ancient DNA is unable to answer many
questions, which makes it difficult to obtain a comprehensive picture of ancient human life. The method
of ancient proteomics analysis undoubtedly complements the techniques of ancient DNA analysis. This
novel study sheds light on the potential of ancient proteomics for obtaining biological information
such as age-related changes or immune system processes, which cannot be extracted from conventional
bioarchaeological methods.
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